価格表

在庫・価格 : 2025年04月30日 20時32分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-PD1, Mouse-Mono(NAT105)
データシート
GTX20256 GNTジーンテックス
GeneTex International Corporation
500 μl ¥112,000
(未発注)
追加

在庫・価格 : 2025年04月30日 20時32分 現在

Anti-PD1, Mouse-Mono(NAT105)

  • 商品コード:GTX20256
  • メーカー:GNT
  • 包装:500μl
  • 価格: ¥112,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Kammerer-Jacquet SF et al. Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential. Int. J. Cancer 2017 Jan;140(1):142-148
Kammerer-Jacquet SF et al
2017/01/01
PubMed
2 Bastman JJ et al. Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer. J. Clin. Endocrinol. Metab. 2016 Jul;101(7):2863-73
Bastman JJ et al
2016/01/01
PubMed
3 Li CW et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun 2016 Aug;7:12632
Li CW et al
2016/01/01
PubMed
4 Dronca RS et al. T cell Bim levels reflect responses to anti-PD-1 cancer therapy. JCI Insight 2016 May;1(6)
Dronca RS et al
2016/01/01
PubMed
5 Paulsen EE et al. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach. Clin Lung Cancer 2017 Mar;18(2):220-233.e8
Paulsen EE et al
2017/01/01
PubMed
6 Kaewkangsadan V et al. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. J Immuno
Kaewkangsadan V et al
2016/01/01
PubMed
7 Mishra V et al. Differential induction of PD-1/PD-L1 in Neuroimmune cells by drug of abuse. Int J Physiol Pathophysiol Pharmacol 2015;7(2):87-97
Mishra V et al
2015/01/01
PubMed
8 Joseph RW et al. Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy. Cancer Immunol Res 2015 Jan;3(1):18-22
Joseph RW et al
2015/01/01
PubMed
9 Smeltzer JP et al. Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma. Clin. Cancer Res. 2014 Jun;20(11):2862-72
Smeltzer JP et al
2014/01/01
PubMed
10 Cogbill CH et al. Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates. Am. J. Clin. Pathol. 2014 Jul;142(1):88-98
Cogbill CH et al
2014/01/01
PubMed
11 Arg端ello RJ et al. Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis. PLoS Negl Trop Dis 2014 Aug;8(8):e2989
Arg端ello RJ et al
2014/01/01
PubMed
12 Szabo K et al. The histopathology of labial salivary glands in primary Sjögren's syndrome: focusing on follicular helper T cells in the inflammatory infiltrates. Mediators Inflamm. 2014;2014:631787
Szabo K et al
2014/01/01
PubMed
13 Verstegen RH et al. Defective B-cell memory in patients with Down syndrome. J. Allergy Clin. Immunol. 2014 Dec;134(6):1346-1353.e9
Verstegen RH et al
2014/01/01
PubMed
14 Liarski VM et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med 2014 Apr;6(230):230ra46
Liarski VM et al
2014/01/01
PubMed
15 Kang MJ et al. Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma. Transl Oncol 2013 Jun;6(3):282-9
Kang MJ et al
2013/01/01
PubMed
16 Sato F et al. Angioimmunoblastic T-cell lymphoma mice model. Leuk. Res. 2013 Jan;37(1):21-7
Sato F et al
2013/01/01
PubMed
17 Sznol M et al. Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. Clin. Cancer Res. 2013 Mar;19(5):1021-34
Sznol M et al
2013/01/01
PubMed
18 Kim JR et al. Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas. PLoS ONE 2013;8(12):e82870
Kim JR et al
2013/01/01
PubMed
19 French JD et al. Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer. J. Clin. Endocrinol. Metab. 2012 Jun;97(6):E934-43
French JD et al
2012/01/01
PubMed
20 Miyoshi H et al. Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders. Am. J. Clin. Pathol. 2012 Jun;137(6):
Miyoshi H et al
2012/01/01
PubMed
21 Bruneau J et al. Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am. J. Pathol. 2010 Aug;177(2):570-4
Bruneau J et al
2010/01/01
PubMed
22 Wada N et al. Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group. Virchows Arch. 2009 Sep;455(3):285-93
Wada N et al
2009/01/01
PubMed
23 Roncador G et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007 Aug;92(8):1059-66
Roncador G et al
2007/01/01
PubMed
24 Zhang S et al. PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas. BMC Cancer 2020 Feb;20(1):127
Zhang S et al
2020/01/01
PubMed
25 Li L, et al., A combination therapy of ingredients from TCM for the prevention and treatment of gastric cancer by targeting HER2/ PD-L1., Pharmacological Research - Modern Chinese Medicine., 2021

PubMed
  • No.: 1
  • 文献情報:
    Kammerer-Jacquet SF et al. Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential. Int. J. Cancer 2017 Jan;140(1):142-148
    Kammerer-Jacquet SF et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Bastman JJ et al. Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer. J. Clin. Endocrinol. Metab. 2016 Jul;101(7):2863-73
    Bastman JJ et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Li CW et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun 2016 Aug;7:12632
    Li CW et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Dronca RS et al. T cell Bim levels reflect responses to anti-PD-1 cancer therapy. JCI Insight 2016 May;1(6)
    Dronca RS et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Paulsen EE et al. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach. Clin Lung Cancer 2017 Mar;18(2):220-233.e8
    Paulsen EE et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kaewkangsadan V et al. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. J Immuno
    Kaewkangsadan V et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Mishra V et al. Differential induction of PD-1/PD-L1 in Neuroimmune cells by drug of abuse. Int J Physiol Pathophysiol Pharmacol 2015;7(2):87-97
    Mishra V et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Joseph RW et al. Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy. Cancer Immunol Res 2015 Jan;3(1):18-22
    Joseph RW et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Smeltzer JP et al. Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma. Clin. Cancer Res. 2014 Jun;20(11):2862-72
    Smeltzer JP et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Cogbill CH et al. Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates. Am. J. Clin. Pathol. 2014 Jul;142(1):88-98
    Cogbill CH et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Arg端ello RJ et al. Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis. PLoS Negl Trop Dis 2014 Aug;8(8):e2989
    Arg端ello RJ et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Szabo K et al. The histopathology of labial salivary glands in primary Sjögren's syndrome: focusing on follicular helper T cells in the inflammatory infiltrates. Mediators Inflamm. 2014;2014:631787
    Szabo K et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Verstegen RH et al. Defective B-cell memory in patients with Down syndrome. J. Allergy Clin. Immunol. 2014 Dec;134(6):1346-1353.e9
    Verstegen RH et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Liarski VM et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med 2014 Apr;6(230):230ra46
    Liarski VM et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Kang MJ et al. Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma. Transl Oncol 2013 Jun;6(3):282-9
    Kang MJ et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Sato F et al. Angioimmunoblastic T-cell lymphoma mice model. Leuk. Res. 2013 Jan;37(1):21-7
    Sato F et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Sznol M et al. Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. Clin. Cancer Res. 2013 Mar;19(5):1021-34
    Sznol M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Kim JR et al. Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas. PLoS ONE 2013;8(12):e82870
    Kim JR et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    French JD et al. Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer. J. Clin. Endocrinol. Metab. 2012 Jun;97(6):E934-43
    French JD et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Miyoshi H et al. Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders. Am. J. Clin. Pathol. 2012 Jun;137(6):
    Miyoshi H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Bruneau J et al. Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am. J. Pathol. 2010 Aug;177(2):570-4
    Bruneau J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Wada N et al. Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group. Virchows Arch. 2009 Sep;455(3):285-93
    Wada N et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Roncador G et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007 Aug;92(8):1059-66
    Roncador G et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Zhang S et al. PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas. BMC Cancer 2020 Feb;20(1):127
    Zhang S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Li L, et al., A combination therapy of ingredients from TCM for the prevention and treatment of gastric cancer by targeting HER2/ PD-L1., Pharmacological Research - Modern Chinese Medicine., 2021

  • 備考:
  • 参照:
    PubMed